India to Philippines: Docetaxel Export Trade Route
India has recorded 170 verified shipments of Docetaxel exported to Philippines, representing a combined trade value of $2.3M USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $13.8K USD. The leading Indian exporter is VEXXA LIFESCIENCES PVT. LTD. , which accounts for 18% of total export value with 17 shipments worth $421.5K USD. On the buying side, VE PHARMA INC is the largest importer in Philippines with $598.9K USD in purchases. The top 3 suppliers — VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., PRIME PHARMACEUTICALS PRIVATE LIMITED — together control 47% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Docetaxel corridor is one of India's established pharmaceutical export routes, with 170 shipments documented worth a combined $2.3M USD. The route is dominated by VEXXA LIFESCIENCES PVT. LTD. , which alone accounts for roughly 18% of all export value, reflecting the consolidated nature of India's docetaxel manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $13.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with docetaxel's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 10.6%, placing it at rank #19 among India's top docetaxel export destinations globally.
On the import side, key buyers of Indian docetaxel in Philippines include VE PHARMA INC, Ve Pharma Inc. , MULTICARE PHARMACEUTICALS PHILIPPIN and 19 others. VE PHARMA INC is the single largest importer with 57 shipments valued at $598.9K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#19
- Annual growth+10.6%
- Demand growth+10.4%
- Regulatory ease77/100
Top 10 Indian Docetaxel Exporters to Philippines
Showing top 10 of 17 Indian suppliers exporting Docetaxel to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VEXXA LIFESCIENCES PVT. LTD. Avg $24.8K per shipment | 17 | $421.5K | 18.0% |
| 2 | VEXXA LIFESCIENCES PVT. LTD. Avg $11.1K per shipment | 33 | $366.8K | 15.6% |
| 3 | PRIME PHARMACEUTICALS PRIVATE LIMITED Avg $15.3K per shipment | 20 | $306.0K | 13.0% |
| 4 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $10.8K per shipment | 21 | $227.3K | 9.7% |
| 5 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $27.1K per shipment | 8 | $217.1K | 9.3% |
| 6 | GETWELL PHARMACEUTICALS Avg $14.5K per shipment | 11 | $159.7K | 6.8% |
| 7 | VEXXA LIFESCIENCES PVT LTD Avg $12.7K per shipment | 10 | $126.5K | 5.4% |
| 8 | INTAS PHARMACEUTICALS LIMITED Avg $7.1K per shipment | 15 | $106.1K | 4.5% |
| 9 | THERDOSE PHARMA PRIVATE LIMITED Avg $15.0K per shipment | 7 | $105.0K | 4.5% |
| 10 | GETWELL PHARMACEUTICALS Avg $10.2K per shipment | 10 | $101.6K | 4.3% |
This table shows the top 10 of 17 Indian companies exporting docetaxel to Philippines, ranked by total trade value. The listed exporters are: VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., PRIME PHARMACEUTICALS PRIVATE LIMITED, VEXXA LIFESCIENCES PRIVATE LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, GETWELL PHARMACEUTICALS, VEXXA LIFESCIENCES PVT LTD, INTAS PHARMACEUTICALS LIMITED, THERDOSE PHARMA PRIVATE LIMITED, GETWELL PHARMACEUTICALS . VEXXA LIFESCIENCES PVT. LTD. is the dominant supplier with 17 shipments worth $421.5K USD, giving it a 18% market share. The top 3 suppliers together account for 47% of the total trade value on this route.
Showing top 10 of 17 total Indian exporters on the India to Philippines Docetaxel export route.
Top 10 Docetaxel Importers in Philippines
Showing top 10 of 22 known buyers in Philippines receiving Docetaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian docetaxel in Philippines include VE PHARMA INC, Ve Pharma Inc. , MULTICARE PHARMACEUTICALS PHILIPPIN, MEDINOVA PHARMACEUTICAL INC., MEDETHIX INC, among 22 total buyers. The largest importer is VE PHARMA INC, accounting for $598.9K USD across 57 shipments — representing 26% of all docetaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VE PHARMA INC | 57 | $598.9K | 25.5% |
| 2 | Ve Pharma Inc. | 17 | $421.5K | 18.0% |
| 3 | MULTICARE PHARMACEUTICALS PHILIPPIN | 6 | $179.6K | 7.7% |
| 4 | MEDINOVA PHARMACEUTICAL INC. | 10 | $171.3K | 7.3% |
| 5 | MEDETHIX INC | 8 | $162.9K | 6.9% |
| 6 | MEDINOVA PHARMACEUTICAL INC | 10 | $134.7K | 5.7% |
| 7 | AMBICA INTERNATIONAL CORPORATION | 9 | $127.7K | 5.4% |
| 8 | AMBICA INTERNATIONAL CORPORATION | 10 | $101.6K | 4.3% |
| 9 | Ve Pharma Inc. | 4 | $80.8K | 3.4% |
| 10 | ACCORD HEALTHCARE LTD (PHILIPPINES) | 7 | $69.0K | 2.9% |
Showing top 10 of 22 Docetaxel importers in Philippines on this route.
Top 10 Docetaxel Formulations Imported by Philippines
Showing top 10 of 114 product formulations shipped on the India to Philippines Docetaxel route, ranked by trade value
Philippines imports a wide range of docetaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Vexdo 80 (DOCETAXEL INJECTION (80MG/2ML) — accounts for $313.0K USD across 14 shipments. There are 114 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Vexdo 80 (DOCETAXEL INJECTION (80MG/2ML) | 14 | $313.0K | 13.4% |
| 2 | Vexdo 80 DOCETAXEL INJECTION 80MG/2MLBCH NO-DCIH23B09-B MANUFACTURING DT-AUG-2023 EXPDT-JUL-2025 | 4 | $83.3K | 3.6% |
| 3 | PHARMACEUTICAL DRUGS AND MEDICINE-TAXTASDOCETAXEL20MG/ML 4ML 1V(AC-PHP) EACH MLCONTAINSCOLON DOCETAXEL ANHYDROUS | 4 | $59.9K | 2.6% |
| 4 | DOCETAXEL AS TRIHYDRATE CONCENTRATESOLUTION FOR IV INFUSION 20MG/ML80MG/4ML DOCETED | 1 | $57.8K | 2.5% |
| 5 | Vexdo 80 (DOCETAXEL INJECTION (80MG/2ML) | 2 | $54.2K | 2.3% |
| 6 | TACEEDO-80 COMBIPACK (DOCETAXEL INJECTION USP CONCENTRATE 80MG/2ML) (2000 VIALS)VLS | 1 | $49.8K | 2.1% |
| 7 | TACEEDO 80 COMBIPACK DOCETAXEL INJECTION USP CONCENTRATE 80MG 2ML 2000 VIALS | 1 | $48.8K | 2.1% |
| 8 | NOVATAXEL 80 DOCETAXEL 40MG ML 80MG 2ML CONCENTRATE SOLUTION FOR IV INFUSION B X5BDO042D M 02 2025 E 01 2028 | 3 | $44.0K | 1.9% |
| 9 | Vexdo 80 Inj DOCETAXEL INJECTION 80MG/ | 2 | $43.2K | 1.8% |
| 10 | VEXDO 20 INJ (DOCETAXEL INJECTION (20MG/ | 1 | $40.1K | 1.7% |
Showing top 10 of 114 Docetaxel formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 53 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's docetaxel exports to Philippines are driven primarily by a handful of large-scale manufacturers. VEXXA LIFESCIENCES PVT. LTD. with 17 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., PRIME PHARMACEUTICALS PRIVATE LIMITED — together account for 47% of total trade value on this route. The average shipment value of $13.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as vexdo 80 docetaxel injection 80mg/2mlbch no-dcih23b09-b manufacturing dt-aug-2023 expdt-jul-2025 and pharmaceutical drugs and medicine-taxtasdocetaxel20mg/ml 4ml 1v(ac-php) each mlcontainscolon docetaxel anhydrous, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, VE PHARMA INC is the largest importer with 57 shipments worth $598.9K USD — representing 26% of all docetaxel imports from India on this route. A total of 22 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.3M
- Avg. Shipment
- $13.8K
- Suppliers
- 17
- Buyers
- 22
- Transit (Sea)
- ~18 days
- Annual Growth
- +10.6%
Other Docetaxel Routes
Unlock the Full India to Philippines Docetaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 170 shipments on this route.
Frequently Asked Questions — India to Philippines Docetaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Docetaxel to Philippines?
The leading Indian exporters of Docetaxel to Philippines are VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., PRIME PHARMACEUTICALS PRIVATE LIMITED. VEXXA LIFESCIENCES PVT. LTD. holds the largest market share at approximately 18% of total trade value on this route.
Q What is the total value of Docetaxel exports from India to Philippines?
India exports Docetaxel to Philippines worth approximately $2.3M USD across 170 recorded shipments. The average value per shipment is $13.8K USD.
Q Which ports does India use to ship Docetaxel to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 53 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Philippines for Docetaxel?
The average transit time for Docetaxel shipments from India to Philippines is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Philippines Docetaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.6% with demand growth tracking at 10.4%. The route is ranked #19 among India's top Docetaxel export destinations globally.
Q How many suppliers are active on the India to Philippines Docetaxel route?
There are currently 17 active Indian suppliers exporting Docetaxel to Philippines. The market is moderately concentrated with VEXXA LIFESCIENCES PVT. LTD. accounting for 18% of total shipment value.
Q Who are the main importers of Docetaxel from India in Philippines?
The leading importers of Indian Docetaxel in Philippines include VE PHARMA INC, Ve Pharma Inc. , MULTICARE PHARMACEUTICALS PHILIPPIN, MEDINOVA PHARMACEUTICAL INC., MEDETHIX INC. VE PHARMA INC is the largest buyer with 57 shipments worth $598.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Docetaxel.
- 2.Supplier/Buyer Matching: 17 Indian exporters and 22 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 170 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
170 Verified Shipments
17 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists